Accelerated Commercial Outcomes Suite

The Accelerated Commercial Outcomes Suite (ACO) by ConcertAI is a comprehensive, AI-powered platform designed to unlock anonymized, patient-centric intelligence for life sciences commercial teams. By rapidly and securely integrating patient-level data in a HIPAA-compliant manner, the suite enables pharmaceutical and biotech organizations to gain deep visibility into patient journeys, treatment pathways, and engagement dynamics — all within a single, intelligent platform.

Built for commercial functions seeking smarter, faster interventions, the ACO Suite links and masters data from multiple sources to power predictive modeling, real-time alerts, and next-best-action recommendations. The platform reduces administrative burden while optimizing patient support programs and improving engagement strategies across patients, payers, and providers.

Key Benefits

• Real-Time Coordination: Accelerates speed-to-insights through rapid integration of specialty pharmacy (SP), claims, social determinants of health (SDoH), and support data into a unified platform with built-in analytics solutions.
• Actionable Insights: Maximizes brand impact by enabling deep data investigation to optimize customer engagement and support across patient segments.
• Smarter Segmentation: Enhances field team effectiveness through AI assistants that deliver predictive alerts, recommend next-best actions, and streamline workflows.
• Improved Outcomes: Identifies key patient segments and fulfillment barriers, enabling timely and targeted interventions to improve patient outcomes.

Cross-Sourced Data Integration

• Capable of merging EMR, claims, payer, lab, and SDoH data with customer SP, hub, and support program sources into a unified data layer.
• Enables deep profiling of the drivers of patient outcomes.
• Enhances forecasting, patient engagement, and support services.
• Built to flexibly integrate both novel and traditional datasets.

Predictive Triggers and Real-Time Alerts

• AI identifies risk points in adherence, access, and therapy switching before patients drop off.
• Sends bi-directional alerts in real time to field and support teams.
• Supports proactive coordination across patient support services.
• Surfaces next-best-intervention strategies based on behavioral models.

Adherence and Intervention Insights

• Models patient drop-off patterns across therapy lines and hub services.
• Identifies social determinants that most influence patient adherence.
• Flags high-risk prescribers and populations for tailored action.
• Supports timely intervention to improve persistence and access.
• Identifies trends in adherence across providers, payers, and pharmacies.

Prescriber Targeting and Behavioral Modeling

• Analyzes prescriber habits, messaging response, and peer influence.
• Enhances outreach using consulting fees, geography, and therapy trends.
• Refines messaging by modeling predicted prescriber behaviors.
• Connects physician behavior to downstream patient access outcomes.

Core Use Cases and Intervention Capabilities

• Adherence optimization through identification of key social determinants and site-level performance.
• Drop-off prevention by uncovering where and why patients disengage from hubs or therapies.
• Physician behavioral targeting by linking consulting activity, prescribing habits, and geography.
• Payer impact analysis comparing brand exposure against formulary, co-pay, and prior authorization actions.
• Next-best-intervention modeling that predicts fill likelihood and surfaces real-time strategies.

The Accelerated Commercial Outcomes Suite is engineered for secure, HIPAA-compliant deployment and is designed to integrate flexibly with a wide range of traditional and novel data sources. As part of ConcertAI's broader commercial solutions portfolio, it delivers a unified view of the patient experience, empowering life sciences organizations to act decisively and drive both brand success and meaningful patient outcomes.